Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome

por Snabes, Michael C., Ng, Juki, Li, Hong, Ali, Izna, Shebley, Mohamad, Schlaff, William D.
Publicado 2023

Delayed Oral Estradiol Combined with Leuprolide Increases Endometriosis-Related Pain

por Hurst, Bradley S., Gardner, Shelia C., Tucker, Kathleen E., Awoniyi, Caleb A., Schlaff, William D.
Publicado 2000

EFFECT OF HORMONAL CONTRACEPTION ON ILLNESS SEVERITY IN WOMEN WITH POSITIVE SARS-CoV2 TESTS

por Mujumdar, Vaidehi, Levy, Ariel T., Madding, Rachel, Berghella, Vincenzo, Quist-Nelson, Johanna, Schlaff, William D., Monseur, Brent C.
Publicado 2020

Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids

por Al-Hendy, Ayman, Bradley, Linda, Owens, Charlotte D., Wang, Hui, Barnhart, Kurt T., Feinberg, Eve, Schlaff, William D., Puscheck, Elizabeth E., Wang, Alice, Gillispie, Veronica, Hurtado, Sandra, Muneyyirci-Delale, Ozgul, Archer, David F., Carr, Bruce R., Simon, James A., Stewart, Elizabeth A.
Publicado 2021

Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas

por Simon, James A., Al-Hendy, Ayman, Archer, David F., Barnhart, Kurt T., Bradley, Linda D., Carr, Bruce R., Dayspring, Thomas, Feinberg, Eve C., Gillispie, Veronica, Hurtado, Sandra, Kim, JinHee, Liu, Ran, Owens, Charlotte D., Muneyyirci-Delale, Ozgul, Wang, Alice, Watts, Nelson B., Schlaff, William D.
Publicado 2020